skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Comparison of three tests for estimating gastroenteral protein loss

Conference · · J. Nucl. Med.; (United States)
OSTI ID:7089160

A decisive step in the diagnosis of exudative gastroenteropathy which shows a pathologically increased transfer of plasma proteins into the stomach or intestine is the measurement of fecal radioactivity after intravenous administration of radionuclide-labeled large organic compounds or of small inorganic compounds attaching themselves to plasma proteins within the patient. In 24 patients (12 men and women each) aged 40 to 66 years, the gastroenteral protein loss was estimated after intravenous injection of Cr-51 chloride, Cr-51 human serum albumin, or Fe-59 iron dextran. Each test lasted 6 days. There was an interval of 2 weeks between 2 tests. The feces were collected completely within the test period for determination of radioactivity. External probe counting over liver, spleen, right kidney, and thyroid was performed daily up to 10 days. The results obtained with Cr-51 chloride presented the largest range whereas the test with Fe-59 iron dextran exhibited both the smallest deviation from the mean value and the lowest normal range. During the tests for gastroenteral protein loss external probe counting demonstrated no distinct tendency to a more rapid radionuclide loss from liver, spleen, and kidney in the patients suffering from exudative gastroenteropathy when compared with healthy subjects. The authors conclude that the most suitable test to estimate gastroenteral protein loss is the Fe-59 iron dextran test although Fe-59 iron dextran is not available commercially and causes a higher radiation burden than the other tests do. In second place, the Cr-51 chloride test should be used, the radiopharmaceutical of which is less expensive and has no significant disadvantage in comparison with Cr-51 human serum albumin.

Research Organization:
Dept. of Nuclear Medicine, Academic Teaching Hospital, Krefeld
OSTI ID:
7089160
Report Number(s):
CONF-840619-
Journal Information:
J. Nucl. Med.; (United States), Vol. 25:5; Conference: 31. annual meeting of the Society of Nuclear Medicine, Los Angeles, CA, USA, 5 Jun 1984
Country of Publication:
United States
Language:
English